With the rapid rise of GLP-1 medications and their transformative impact on metabolic health, the food and beverage industry embarks upon a new era of innovation. GLP-1 receptor agonists—originally developed for diabetes and now widely adopted for weight management—are reshaping consumer habits, nutritional needs, and product expectations. 

This session explores the health impact and market trends driving the GLP-1 revolution using unique consumer insights. We’ll examine how GLP-1 drugs are changing eating patterns, reducing “food noise,” and shifting demand toward high-protein, nutrient-dense, and portion-controlled foods—especially in categories like yogurt and plant-based dairy. With more than 1 in 8 U.S. adults having tried GLP-1 medications, and new oral formulations and generics on the horizon, the market is set for explosive growth.

Key topics include:

• The evolution and adoption of GLP-1 therapies and their impact on global health

• How GLP-1 is influencing grocery spending, food choices, and the future of product development

• Consumer research findings: changing attitudes toward nutrition, portion size, and ingredient transparency

• Opportunities for brands to create products that meet the evolving needs of GLP-1 users—focusing on protein, probiotics, clean labels, and convenient formats